Phase 2 of the Airlock will include seven additional technologies spanning AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection tools, and obesity treatment support systems.
UK MHRA · October 16, 2025
MHRA AI Airlock Phase 2 Cohort: Guidance
Original title: Guidance: AI Airlock Phase 2 Cohort
Phase 2 of the Airlock programme includes seven AI-powered technologies for clinical note-taking, cancer diagnostics, eye disease detection, and obesity treatment.
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.